Use of Research Results Sample Clauses

Use of Research Results. The Research results will belong to Data User and may be retained by Data User. However, Yale is free to publicly post the results after DUA expiration with appropriate acknowledgment of Data User.
Sample 1Sample 2Sample 3See All (11)
AutoNDA by SimpleDocs
Use of Research Results. Each Party may use Research Results for any purpose. However, in the case of Sponsor, the use may not infringe any claim of a patent application or an issued patent included in University Intellectual Property rights for which Sponsor has failed to obtain a license as provided in Section 5.5.
Sample 1Sample 2Sample 3See All (7)
Use of Research Results. 8.1.1 Copyright to copyrightable materials, including computer software, resulting from Research Projects shall vest in University with a royalty-free non-exclusive, non-sublicensable license to Sponsor for its Non-Commercial use. “
Sample 1Sample 2See All (5)
Use of Research Results. The Research results will belong to User and may be retained by User. However, the University is free to publicly post the results with appropriate acknowledgment of User.
Sample 1Sample 2
Use of Research Results. Each Party may use Research Results for any purpose. However, in the case of Sponsor, the use may not infringe any claim of a patent application or an issued patent included in Institution Intellectual Property rights for which Sponsor has failed to obtain a license. Copyrightable Works. Institution or its employees own any copyrighted or copyrightable works (including reports and publications) that are created by Institution employees in the performance of the Study. Institution and the Principal Investigator grant Sponsor an irrevocable, royalty-free, nontransferable, non-exclusive right to copy and distribute for internal purposes only any Copyrightable Works that are furnished to Sponsor under this Agreement.
Sample 1
Use of Research Results. The Research results, including scientific findings and copyrights in any manuscripts, will belong to Data User and may be retained by Data User. However, Yale is free to publicly post the results after DUA expiration with appropriate acknowledgment of Data User. Patentable subject matter and intellectual property capable of commercial exploitation and directly related to the Products shall be governed by Section 9 of this Agreement.
Sample 1
Use of Research Results. If ARS exercises the License Right, ARS shall be free to use the Axonyx Know-How, the Ares Serono Know-How and the Axonyx and/or ARS Patent Rights in accordance with the License Agreement to be entered into between the parties as contemplated in Article III hereof. If ARS does not exercise the License Right, all right, title and interest in and to all Axonyx Know-How, Axonyx Patent Rights, Ares Serono Know-How and Ares Serono Patent Rights shall revert to or vest in Axonyx. ARS agrees that if the License Period expires without its exercise of the License Right, ARS will promptly transfer all ARS Know-How to Axonyx and will promptly assign its interest in the ARS Patent Rights to Axonyx. Axonyx shall be free to utilize such ARS Know-How and Patent Rights without any restriction or obligation including any confidentiality obligation.
Sample 1
AutoNDA by SimpleDocs
Use of Research Results. SPONSOR may use Research Results for internal research only. For the avoidance of doubt SPONSOR may not use Research Results for any commercial purpose, including sale, lease, license, or other transfer of the Research Results to another organization.
Sample 1

Related to Use of Research Results

  • Research Records Each Party shall maintain records of each Research Program (or cause such records to be maintained) in sufficient detail and in good scientific manner as will properly reflect all work done and results achieved by or on behalf of such Party in the performance of such Research Program. All laboratory notebooks shall be maintained for no less than the term of any Patent issuing therefrom. All other records shall be maintained by each Party during the relevant Research Term and for [**] thereafter. All such records of a Party shall be considered such Party’s Confidential Information.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Patent Listings Licensee shall have the right and responsibility to make all filings with Regulatory Authorities in the Territory with respect to the AstraZeneca Patents, including as required or allowed (i) in the United States, in the FDA’s Orange Book and (ii) in the European Union, under the national implementations of Article 10.1(a)(iii) of Directive 2001/EC/83 or other international equivalents; provided that Licensee shall consult with AstraZeneca to determine the course of action with respect to such filings.

  • Technical Information The Employer agrees to provide to the Union such information that is available relating to employees in the bargaining unit, as may be required by the Union for collective bargaining purposes.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Software Computer program(s) provided by Contractor in connection with the Deliverables, subject to Section 14 of this Contract.

  • No Improper Use of Materials During his or her employment with the Company, Employee will not improperly use or disclose any Confidential Information or trade secrets, if any, of any former employer or any other person to whom Employee has an obligation of confidentiality, and Employee will not bring onto the premises of the Company any unpublished documents or any property belonging to any former employer or any other person to whom Employee has an obligation of confidentiality unless consented to in writing by that former employer or person.

  • Search Results Copies of UCC search reports dated such a date as is reasonably acceptable to Lender, listing all effective financing statements which name each Credit Party, under its present name and any previous names, as debtors, together with copies of such financing statements.

Time is Money Join Law Insider Premium to draft better contracts faster.